Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements - Contingent Consideration (Details)

v3.21.2
Fair Value Measurements - Contingent Consideration (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Feb. 25, 2019
Fair Value Measurements      
Contingent consideration under royalty purchase agreements $ 75 $ 75  
Bioasis Technologies Inc [Member] | Royalty Purchase Agreement [Member]      
Fair Value Measurements      
Changes in estimated fair value of contingent consideration $ 0    
Contingent consideration under royalty purchase agreements     $ 100